Pharmacological inhibition of METTL1 as a therapy against solid and blood cancers.

Yankova, Eliza, Sapetschnig, Alexandra, Thomas, Beth, Evans, Siân, Eleftheriou, Maria, Gozdecka, Malgorzata, Fischl, Harry, Brevini, Teresa, Wilson, Rachael, Bucknell, Sarah J, Hutchin, Andrew, Livi, Carmen M, Giotopoulos, George, Asby, Ryan, Bond, Laura, Azevedo, Aleksandra, Webster, Natalie, Rogan, Jack, Russell, James, Andrews, Byron, Weisser, Hendrik, Baxter, Joanna, López-Luis, Judith, Mantica, Giovanna, Tobin, Jake, Lopez-Leon, Diego, Pask, Dean C, Tandon, Vidur, Fosbeary, Richard, Sawyer, Sapphire, Usluer, Sunay, Joseph, Nithila, Stamou, Evangelia, Bejar, Maria T, Malam, Yogeshkumar, Rad, Roland, Laurenti, Elisa, Li, Juan, Alcolea, Maria P, Adams, David J, Khaled, Walid T, Sampaziotis, Fotios, Vassiliou, George S, Huntly, Brian JP, Rausch, Oliver, Tzelepis, Konstantinos

Open source

DOI: 10.17863/cam.134595
Published: 2026
Container: Not recorded
Publisher: Springer Science and Business Media LLC
Open access: yes

Credibility signals

limited evidence Score 47/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingPublication license: A publication license was supplied: https://creativecommons.org/licenses/by/4.0/legalcode. Presence improves reuse transparency, not research validity. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.17863/cam.134595,
  title = {Pharmacological inhibition of METTL1 as a therapy against solid and blood cancers.},
  author = {Yankova, Eliza and Sapetschnig, Alexandra and Thomas, Beth and Evans, Siân and Eleftheriou, Maria and Gozdecka, Malgorzata and Fischl, Harry and Brevini, Teresa and Wilson, Rachael and Bucknell, Sarah J and Hutchin, Andrew and Livi, Carmen M and Giotopoulos, George and Asby, Ryan and Bond, Laura and Azevedo, Aleksandra and Webster, Natalie and Rogan, Jack and Russell, James and Andrews, Byron and Weisser, Hendrik and Baxter, Joanna and López-Luis, Judith and Mantica, Giovanna and Tobin, Jake and Lopez-Leon, Diego and Pask, Dean C and Tandon, Vidur and Fosbeary, Richard and Sawyer, Sapphire and Usluer, Sunay and Joseph, Nithila and Stamou, Evangelia and Bejar, Maria T and Malam, Yogeshkumar and Rad, Roland and Laurenti, Elisa and Li, Juan and Alcolea, Maria P and Adams, David J and Khaled, Walid T and Sampaziotis, Fotios and Vassiliou, George S and Huntly, Brian JP and Rausch, Oliver and Tzelepis, Konstantinos},
  year = {2026},
  doi = {10.17863/cam.134595},
  url = {https://doi.org/10.17863/cam.134595}
}

RIS

TY  - JOUR
TI  - Pharmacological inhibition of METTL1 as a therapy against solid and blood cancers.
AU  - Yankova, Eliza
AU  - Sapetschnig, Alexandra
AU  - Thomas, Beth
AU  - Evans, Siân
AU  - Eleftheriou, Maria
AU  - Gozdecka, Malgorzata
AU  - Fischl, Harry
AU  - Brevini, Teresa
AU  - Wilson, Rachael
AU  - Bucknell, Sarah J
AU  - Hutchin, Andrew
AU  - Livi, Carmen M
AU  - Giotopoulos, George
AU  - Asby, Ryan
AU  - Bond, Laura
AU  - Azevedo, Aleksandra
AU  - Webster, Natalie
AU  - Rogan, Jack
AU  - Russell, James
AU  - Andrews, Byron
AU  - Weisser, Hendrik
AU  - Baxter, Joanna
AU  - López-Luis, Judith
AU  - Mantica, Giovanna
AU  - Tobin, Jake
AU  - Lopez-Leon, Diego
AU  - Pask, Dean C
AU  - Tandon, Vidur
AU  - Fosbeary, Richard
AU  - Sawyer, Sapphire
AU  - Usluer, Sunay
AU  - Joseph, Nithila
AU  - Stamou, Evangelia
AU  - Bejar, Maria T
AU  - Malam, Yogeshkumar
AU  - Rad, Roland
AU  - Laurenti, Elisa
AU  - Li, Juan
AU  - Alcolea, Maria P
AU  - Adams, David J
AU  - Khaled, Walid T
AU  - Sampaziotis, Fotios
AU  - Vassiliou, George S
AU  - Huntly, Brian JP
AU  - Rausch, Oliver
AU  - Tzelepis, Konstantinos
PY  - 2026
DO  - 10.17863/cam.134595
UR  - https://doi.org/10.17863/cam.134595
ER  -

APA

Eliza, Y., Alexandra, S., Beth, T., Siân, E., Maria, E., Malgorzata, G., Harry, F., Teresa, B., Rachael, W., J, B. S., Andrew, H., M, L. C., George, G., Ryan, A., Laura, B., Aleksandra, A., Natalie, W., Jack, R., James, R., Byron, A., Hendrik, W., Joanna, B., Judith, L., Giovanna, M., Jake, T., Diego, L., C, P. D., Vidur, T., Richard, F., Sapphire, S., Sunay, U., Nithila, J., Evangelia, S., T, B. M., Yogeshkumar, M., Roland, R., Elisa, L., Juan, L., P, A. M., J, A. D., T, K. W., Fotios, S., S, V. G., JP, H. B., Oliver, R., & Konstantinos, T. (2026). Pharmacological inhibition of METTL1 as a therapy against solid and blood cancers.. https://doi.org/10.17863/cam.134595

Source records

datacite · retrieved 2026-11-03T10:49:51.646Z